Spinocerebellar Ataxia Type 2 Latest Advances

Find the Latest Research About Spinocerebellar Ataxia Type 2

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 516 publications

Subcortical shape alterations in spinocerebellar ataxia type 2: a longitudinal MRI-based analysis.

Subcortical shape alterations in spinocerebellar ataxia type 2: a longitudinal MRI-based analysis.

Journal: Acta neurologica Belgica

Published: May 08, 2026

Blood Glucose Homeostasis is Preserved in Patients with Mild-to-moderate Spinocerebellar Ataxia Type 2.

Blood Glucose Homeostasis is Preserved in Patients with Mild-to-moderate Spinocerebellar Ataxia Type 2.

Journal: Cerebellum (London, England)

Published: April 25, 2026

Improving the Identification of the Preclinical Stages of Spinocerebellar Ataxia Type 2.

Improving the Identification of the Preclinical Stages of Spinocerebellar Ataxia Type 2.

Journal: Tomography (Ann Arbor, Mich.)

Published: April 03, 2026

N140 Latency as a Novel Biomarker for the Evaluation of Somatosensory Dysfunction in Patients with Spinocerebellar Ataxia Type 2.

N140 Latency as a Novel Biomarker for the Evaluation of Somatosensory Dysfunction in Patients with Spinocerebellar Ataxia Type 2.

Journal: Cerebellum (London, England)

Published: March 05, 2026

Auditory P300 Potentials as State Biomarkers for Mild-to-Moderate Depression in Spinocerebellar Ataxia Type 2.

Auditory P300 Potentials as State Biomarkers for Mild-to-Moderate Depression in Spinocerebellar Ataxia Type 2.

Journal: Cerebellum (London, England)

Published: February 20, 2026

Behavioral and Personality Changes as the First Manifestation of Spinocerebellar Ataxia Type 2.

Behavioral and Personality Changes as the First Manifestation of Spinocerebellar Ataxia Type 2.

Journal: Cerebellum (London, England)

Published: February 11, 2026

Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulation.

Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulation.

Journal: Journal of neuroimmunology

Published: February 04, 2026

Validation of the SODA in Spinocerebellar Ataxia Type 2.

Validation of the SODA in Spinocerebellar Ataxia Type 2.

Journal: Cerebellum (London, England)

Published: January 03, 2026

Monitoring the Progression of Pre-Ataxic Gait in SCA2 with Inertial Sensors Over Four Years.

Monitoring the Progression of Pre-Ataxic Gait in SCA2 with Inertial Sensors Over Four Years.

Journal: Cerebellum (London, England)

Published: November 20, 2025

Genomic Organization, Evolutionary Conservation and Expression of Ataxin-2 and Ataxin-2-like Genes Underscore the Suitability of Zebrafish as a Model Organism for SCA2 and Related Diseases.

Genomic Organization, Evolutionary Conservation and Expression of Ataxin-2 and Ataxin-2-like Genes Underscore the Suitability of Zebrafish as a Model Organism for SCA2 and Related Diseases.

Journal: Biomedicines

Published: November 12, 2025

Rare but Instructive: Pediatric-Onset Spinocerebellar Ataxia Type 2 and Its Clinical and Genetic Insights.

Rare but Instructive: Pediatric-Onset Spinocerebellar Ataxia Type 2 and Its Clinical and Genetic Insights.

Journal: Cerebellum (London, England)

Published: October 15, 2025

Targeting Cognitive Dysfunction in Spinocerebellar Ataxia Type 2 Through Digital Cognitive Training.

Targeting Cognitive Dysfunction in Spinocerebellar Ataxia Type 2 Through Digital Cognitive Training.

Journal: Cerebellum (London, England)

Published: October 09, 2025

Showing 1-12 of 516

Last Updated: 09/26/2026